We are live on !
Find out more
Point72 (DIFC) Portfolio holdings
AUM
$1.53B
Turnover
69.25%
1-Year Est. Return
15.83%
This Fund
S&P 500
This Quarter Est. Return
+4.78%
1 Year Est. Return
+15.83%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.53B
AUM Growth
-$1.12B
(-42%)
Cap. Flow
+$151M
Cap. Flow % of AUM
Cap. Flow %
9.87%
Top 10 Holdings %
Top 10 Hldgs %
24.76%
Holding
1,997
New
503
Increased
228
Reduced
372
Closed
880
Avg Time Held
Equity + Options
0.4
years
Top 10 Avg Time Held
Equity + Options
0.1
years
Top 20 Avg Time Held
Equity + Options
0.1
years
Avg Time Held Equity only
0.2
years
Top 10 Avg Time Held Equity only
0.1
years
Top 20 Avg Time Held Equity only
0.2
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$44.7M |
| 2 |
Microsoft
MSFT
|
+$41.9M |
| 3 |
Boston Scientific
BSX
|
+$27.2M |
| 4 |
Visa
V
|
+$26.6M |
| 5 |
TSMC
TSM
|
+$25.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$30.4M |
| 2 |
Analog Devices
ADI
|
+$24.4M |
| 3 |
Thermo Fisher Scientific
TMO
|
+$24.4M |
| 4 |
GE Aerospace
GE
|
+$22.9M |
| 5 |
Lam Research
LRCX
|
+$21.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 25.12% |
| 2 | Technology | 23.11% |
| 3 | Financials | 13.26% |
| 4 | Communication Services | 8.27% |
| 5 | Consumer Discretionary | 7.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1076
Townsquare Media
TSQ
$54.1M
| $625 | ﹤0.01% |
+93
| New | +$673 |
2025 Q3
0 quarters
|
|
1077
Denali Therapeutics
DNLI
$3.03B
| $622 | ﹤0.01% |
+43
| New | +$618 |
2025 Q3
0 quarters
|
|
1078
Spok Holdings
SPOK
$251M
| $601 | ﹤0.01% |
+35
| New | +$623 |
2025 Q3
0 quarters
|
|
1079
Achieve Life Sciences
ACHV
$704M
| $595 | ﹤0.01% |
+189
| New | +$519 |
2025 Q3
0 quarters
|
|
1080
Star Holdings Shares of Beneficial Interest
STHO
$90.2M
| $593 | ﹤0.01% |
72
-828
| -92% | -$6.72K |
2025 Q2
1 quarter
|
|
1081
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $587 | ﹤0.01% |
871
-323
| -27% | -$174 |
2025 Q1
2 quarters
|
|
1082
Cardlytics
CDLX
$10.5M
| $558 | ﹤0.01% |
23
| – | – |
2025 Q1
2 quarters
|
|
1083
Under Armour Class C
UA
$2.08B
| $545 | ﹤0.01% |
+113
| New | +$632 |
2025 Q3
0 quarters
|
|
1084
Black Diamond Therapeutics
BDTX
$102M
| $544 | ﹤0.01% |
143
-7,081
| -98% | -$20.7K |
2025 Q2
1 quarter
|
|
1085
Century Therapeutics
IPSC
$266M
| $530 | ﹤0.01% |
1,064
-685
| -39% | -$369 |
2025 Q2
1 quarter
|
|
1086
C4 Therapeutics
CCCC
$415M
| $519 | ﹤0.01% |
234
-3,719
| -94% | -$8.93K |
2025 Q2
1 quarter
|
|
1087
Geospace Technologies
GEOS
$57M
| $507 | ﹤0.01% |
+27
| New | +$437 |
2025 Q3
0 quarters
|
|
1088
Orion Office REIT
ONL
$135M
| $491 | ﹤0.01% |
182
-14,053
| -99% | -$37.6K |
2025 Q2
1 quarter
|
|
1089
Purple Innovation
PRPL
$13.1M
| $464 | ﹤0.01% |
20
| – | – |
2025 Q2
1 quarter
|
|
1090
Full House Resorts
FLL
$30.3M
| $462 | ﹤0.01% |
144
-2,423
| -94% | -$9.5K |
2025 Q2
1 quarter
|
|
1091
Sprinklr
CXM
$1.58B
| $430 | ﹤0.01% |
+56
| New | +$472 |
2025 Q3
0 quarters
|
|
1092
Yatsen Holding
YSG
$211M
| $425 | ﹤0.01% |
47
-5
| -10% | -$48 |
2025 Q2
1 quarter
|
|
1093
Ocugen
OCGN
$238M
| $422 | ﹤0.01% |
259
-16,609
| -98% | -$18.4K |
2025 Q2
1 quarter
|
|
1094
DELISTED
RAPT Therapeutics
RAPT
| $405 | ﹤0.01% |
+16
| New | +$209 |
2025 Q3
0 quarters
|
|
1095
Aemetis
AMTX
$90.2M
| $383 | ﹤0.01% |
170
-646
| -79% | -$1.72K |
2025 Q2
1 quarter
|
|
1096
GoodRx Holdings
GDRX
$1.19B
| $382 | ﹤0.01% |
90
-2,440
| -96% | -$10.7K |
2025 Q2
1 quarter
|
|
1097
DocGo
DCGO
$24.4M
| $379 | ﹤0.01% |
+279
| New | +$422 |
2025 Q3
0 quarters
|
|
1098
Lantronix
LTRX
$282M
| $352 | ﹤0.01% |
+77
| New | +$285 |
2025 Q3
0 quarters
|
|
1099
Castellum
CTM
$46M
| $337 | ﹤0.01% |
+309
| New | +$359 |
2025 Q3
0 quarters
|
|
1100
MacroGenics
MGNX
$153M
| $319 | ﹤0.01% |
190
| – | – |
2025 Q2
1 quarter
|
|
Similar funds
Point72 (DIFC)'s Q3 2025 Portfolio in Review
As of Q3 2025, Point72 (DIFC) held 1,997 positions worth $1.53B, down 42% from $2.64B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Point72 (DIFC) deployed $151M of net new capital in Q3 2025, opening 503 new positions and adding to 228 existing holdings. Its largest new stake was Visa: 76,800 shares worth $26.2M.
By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 14% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Analog Devices, an estimated $24.4M trimmed.
- Point72 (DIFC)'s largest Q3 2025 buy was Visa: 76,800 shares worth $26.2M.
- Point72 (DIFC) added most to Meta Platforms (Facebook) in Q3 2025, an estimated $44.7M increase.
- Point72 (DIFC)'s biggest Q3 2025 reduction was Analog Devices, cutting an estimated $24.4M.
- Point72 (DIFC) fully exited NVIDIA in Q3 2025, selling an estimated $30.4M.
- Point72 (DIFC)'s ten largest holdings make up 25% of its $1.53B portfolio in Q3 2025.
- Point72 (DIFC) opened 503 new positions and closed 880 in Q3 2025.
- Point72 (DIFC)'s portfolio value fell 42% quarter-over-quarter to $1.53B.
Based on Point72 (DIFC)'s 13F filing for Q3 2025, filed 14 Nov 2025.